title: Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib.
authors.affiliation: Department of Dermatology, Chelsea & Westminster Hospital NHS Foundation Trust, London, UK. rs280@doctors.org.uk
authors.forename: Rishika
authors.initials: R
authors.lastname: Sinha
authors.forename: Kim
authors.initials: K
authors.lastname: Edmonds
authors.forename: Julia
authors.initials: J
authors.lastname: Newton-Bishop
authors.forename: Martin
authors.initials: M
authors.lastname: Gore
authors.forename: James
authors.initials: J
authors.lastname: Larkin
authors.forename: Louise
authors.initials: L
authors.lastname: Fearfield
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004893:Erythema Nodosum / Q000175:diagnosis; D005260:Female; D018698:Glutamic Acid; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D015434:Panniculitis / Q000139:chemically induced* / Q000175:diagnosis*; D017354:Point Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000235:genetics; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D014633:Valine; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D018698:Glutamic Acid; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D014633:Valine